Synchronous Primary Ovarian and Endometrial Cancer With a Fair Prognosis in a Young Woman

Lin M.-CYang Y.-HRUEY-JIEN CHENCheng S.-PTING-CHEN CHANG2020-02-172020-02-1720101028-4559https://scholars.lib.ntu.edu.tw/handle/123456789/459813[SDGs]SDG3CA 125 antigen; carboplatin; cyclophosphamide; dydrogesterone; estradiol; paclitaxel; abdominal hysterectomy; adult; anemia; ascites; case report; clear cell carcinoma; computer assisted tomography; drug hypersensitivity; drug withdrawal; endometrium cancer; endometrium carcinoma; endometrium hyperplasia; female; histopathology; human; incidental finding; letter; liver hemangioma; menopausal syndrome; multiple cycle treatment; ovary carcinoma; postoperative period; primary tumor; prognosis; salpingooophorectomy; spotting; transvaginal echography; tumor volume; Adenocarcinoma, Clear Cell; Adult; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Endometrial Neoplasms; Female; Humans; Hysterectomy; Neoplasms, Multiple Primary; Ovarian NeoplasmsSynchronous Primary Ovarian and Endometrial Cancer With a Fair Prognosis in a Young Womanletter10.1016/S1028-4559(10)60019-8204663032-s2.0-77953246191